ProShare Advisors
GEVA

ProShare Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

ProShare Advisors’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$3.34M Buy
2014
Q4 		$2.47M Buy
2014
Q3 		$1.76M Sell
2014
Q2 		$3.19M Sell
2014
Q1 		$3.56M Buy
2013
Q4 		$965K Sell
2013
Q3 		$1.29M Buy
2013
Q2 		$526K Buy